Avenue Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
OID
Avenue Therapeutics, Inc. announced its virtual Annual Meeting of Stockholders for December 30, 2025, to elect directors and ratify KPMG LLP as its independent auditor.
OID
Avenue Therapeutics has filed a definitive proxy statement with the Securities and Exchange Commission.
OID
Avenue Therapeutics is holding its annual stockholder meeting on June 24, 2024, to vote on the election of directors, ratification of auditors, and an amendment to the company's incentive plan.
OID
Avenue Therapeutics' board of directors has approved a reverse stock split, ranging from 30-for-1 to 75-for-1, to increase its stock price and maintain its Nasdaq listing.